Regional Business Manager - New Jersey
Intellia Therapeutics, Inc.
July 01, 2026
On-site
Cambridge, MA
Sales
Responsibilities:
- Develop and execute territory plans targeting immunologists, allergists, emergency medicine physicians, and specialized HAE treatment centers (territory: New Jersey)
- Identify and prioritize high-value accounts based on HAE patient volume, prescriber influence, and institutional capabilities
- Build trusted advisor relationships with key opinion leaders, clinical champions, and administrative decision-makers
- Maintain a robust sales pipeline from initial awareness through patient treatment completion
- Educate providers on in vivo CRISPR gene editing mechanisms; differentiate from ex vivo cell therapies and traditional treatments
- Articulate the unique mechanism of action vs. prophylactic treatments, complement inhibitors, and plasma-derived therapies; present Phase III efficacy and safety data
- Address misconceptions about CRISPR safety and differentiate from prior gene therapy launches; educate on unmet needs and treatment burden
- Maintain competitive intelligence and emerging-therapy awareness; develop differentiated value propositions
- Proactively handle objections related to CRISPR technology, permanent genetic modification, and single-treatment cost
- Educate on patient journey from diagnosis confirmation through treatment administration; coordinate with patient support hubs
- Coordinate with Medical Affairs/Medical Science Liaisons and align with Field Reimbursement Managers on payer strategy and coverage
- Partner with strategic accounts team on referral patterns, site selection, and site activation
Qualifications:
- BS/BA in life sciences or business-related field
- Comprehensive knowledge of hereditary angioedema pathophysiology, treatment landscape, and unmet medical needs
- Understanding of gene editing technologies, genetic medicines, and regulatory requirements
- Ability to analyze and present complex clinical trial data and real-world evidence
- 5+ years specialty pharmaceutical sales experience (preferably rare disease, immunology, or genetic medicines)
- Proven rare disease commercialization track record; experience with first-in-class/novel mechanism product launches
- Demonstrated success in long sales cycles (12–18 months) with multiple stakeholders
- Required skills: exceptional scientific communication; long-term stakeholder relationship management; problem solving for access barriers; collaboration; growth/competitive mindset; business-owner execution
Preferred:
- Rare disease, gene therapy, and HAE market knowledge (preferred but not required)
Application:
- Applications accepted on a rolling basis until the position is filled.
- Develop and execute territory plans targeting immunologists, allergists, emergency medicine physicians, and specialized HAE treatment centers (territory: New Jersey)
- Identify and prioritize high-value accounts based on HAE patient volume, prescriber influence, and institutional capabilities
- Build trusted advisor relationships with key opinion leaders, clinical champions, and administrative decision-makers
- Maintain a robust sales pipeline from initial awareness through patient treatment completion
- Educate providers on in vivo CRISPR gene editing mechanisms; differentiate from ex vivo cell therapies and traditional treatments
- Articulate the unique mechanism of action vs. prophylactic treatments, complement inhibitors, and plasma-derived therapies; present Phase III efficacy and safety data
- Address misconceptions about CRISPR safety and differentiate from prior gene therapy launches; educate on unmet needs and treatment burden
- Maintain competitive intelligence and emerging-therapy awareness; develop differentiated value propositions
- Proactively handle objections related to CRISPR technology, permanent genetic modification, and single-treatment cost
- Educate on patient journey from diagnosis confirmation through treatment administration; coordinate with patient support hubs
- Coordinate with Medical Affairs/Medical Science Liaisons and align with Field Reimbursement Managers on payer strategy and coverage
- Partner with strategic accounts team on referral patterns, site selection, and site activation
Qualifications:
- BS/BA in life sciences or business-related field
- Comprehensive knowledge of hereditary angioedema pathophysiology, treatment landscape, and unmet medical needs
- Understanding of gene editing technologies, genetic medicines, and regulatory requirements
- Ability to analyze and present complex clinical trial data and real-world evidence
- 5+ years specialty pharmaceutical sales experience (preferably rare disease, immunology, or genetic medicines)
- Proven rare disease commercialization track record; experience with first-in-class/novel mechanism product launches
- Demonstrated success in long sales cycles (12–18 months) with multiple stakeholders
- Required skills: exceptional scientific communication; long-term stakeholder relationship management; problem solving for access barriers; collaboration; growth/competitive mindset; business-owner execution
Preferred:
- Rare disease, gene therapy, and HAE market knowledge (preferred but not required)
Application:
- Applications accepted on a rolling basis until the position is filled.